Clin2
NCT07545616Possibly a fitRecruiting

Finding biomarkers for femoral head bone death

Osteonecrosis of the Femoral Head

Part of Bones, joints & muscles clinical trials.

This study looks for biological signs (biomarkers) that can help identify and understand osteonecrosis of the femoral head—a condition where bone in the hip dies. Researchers hope these signs will improve how doctors diagnose and treat the condition.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
300 people
Ages
18 years to 70 years
Study type
Observational

Who can take part

  • You are between 18 and 70 years old
  • You have suspected or confirmed osteonecrosis of the femoral head (bone death in the hip)
  • You do not have a history of hip trauma or injury
  • You do not have hip-related fractures or dislocations from trauma
  • You are able to complete questionnaires and understand the study
  • You can provide informed consent and agree to participate

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06123481Recruiting
Bone marrow treatment for early hip bone loss

This trial tests whether injecting your own bone marrow into the hip can help heal early-stage osteonecrosis (bone death) before the bone collapses. It is for people who have not had prior hip surgery and do not have certain conditions like sickle cell disease.

Los Angeles, California
NCT07101562Recruiting
Repairing hip bone damage with your own stem cells

This study is testing a new way to repair the damaged bone in your hip by using your own bone marrow stem cells. You may be a candidate if you have femoral head necrosis (hip bone death) that did not get better with standard treatments and you are otherwise healthy enough for surgery.

Xinxiang, Henan
NCT07544823Recruiting
Study of Early Markers for Osteoarthritis

This study looks for early signs of osteoarthritis (joint wear and tear) in your blood or other samples. Understanding these markers may help doctors detect and treat osteoarthritis sooner.

Xinxiang, Henan
NCT07787923Not yet recruiting· Early Phase 1
Stem cell exosome injection for early hip necrosis

This study tests a new treatment using stem cell exosomes injected into the hip joint for people with early-stage non-traumatic avascular necrosis of the femoral head (a condition where bone tissue in the hip dies due to poor blood supply, not caused by injury). The goal is to see if it is safe and may help improve hip function and pain.

NCT05732870Recruiting
Study looks for blood and gene signals that affect bone health

This study collects information and samples around the time of certain bone or joint surgeries (like joint replacement or fracture repair) to learn what factors help or harm bone healing. The results may help find better targets to improve long-term bone health and recovery.

London, Greater London
NCT06525688Recruiting
Osteoporosis study using bone tissue to find new targets

This study looks for new markers and treatment targets for osteoporosis by comparing bone tissue from women with a broken hip (due to weak bones) and women getting a hip replacement for arthritis. You may be eligible if you are postmenopausal and have one of these hip conditions.

Kifissia, Attica

Hear when a new Osteonecrosis of the Femoral Head trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.